- Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma.
Rev Infect Dis 1987; 9:908–916. - Gossling J. The occurrence and pathogenicity of the S milleri group. Rev Infect Dis 1988; 10:257.
- Murdoch DR, Reller LB. Antimicrobial susceptibility group B streptococci isolated from patients
with invasive disease: 10-year prospective. Antimicrob Agents Chemother 2001; 45:3623–3624. - Phares CR, Lynnfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease
in the United States, 1999–2005. JAMA 2008; 299:2056–2065. - Sambola A, Miro JM, Tornos MP, et al. Streptococcus agalactiae infective endocarditis: analysis of
30 cases in review of the literature, 1962–1998. Clin Infect Dis 2002; 34:1576–1582.
16a. Maki DG, Agger WA. Enterococcal bacteremia: Clinical features, the risk of endocarditis, and
management. Medicine (Baltimore) 1988; 67:248–269. - Brusch JL. Cardiac infections in the immunosuppressed patient. Infect Dis Clin NA 2001:15:613–638.
- West SK, Plantenga MS, Strausbaugh LJ, and Infectious Diseases Society of America Emerging
Infectious Network. Culture-negative endocarditis and endocarditis caused by unusual pathogens
including vancomycin-resistant enterococci: results of an emerging infections network survey.
Infect Dis Clin Pract 2007; 15:316–319. - Stevens MP, Edmond MB. Endocarditis due to vancomycin-resistant enterococci: case report and
review of the literature. Clin Infect Dis 2005; 41:1134–1142. - Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy
and management of complications: a statement for health care professionals From the Committee
on Rheumatic Fever, Endocarditis and on Clinical Cardiology, Stroke and Cardiovascular Surgery
and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of
America. Circulation 2005; 111: e394–e434. - Duval X, Papastamopoulos V, Longuet P, et al. Definite Streptococcus bovis endocarditis:
characteristics in 20 patients. Clin Microbiol Infect 2001, 7:3—10. - Moellering RC, Watson BK Kunz L. Endocarditis due to group D. streptococci. Comparison of
disease caused by Streptococcus bovis with that caused by the enterococci Am J Med 1974; 57:
239–250. - Petti CA, Fowler VG. Staphylococcus aureus bacteremia and endocarditis. In: Durack DT, ed.
Infective Endocarditis. Philadelphia: WB Saunders, 2002:413–435. - Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345:1318–1330.
- Wiplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in U.S. hospitals:
analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;
39:309–317. - Beekman S, Henderson DK. Infections caused by percutaneous intravascular devices. In: Mandel
GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, Chapter 300. 6th ed.
Philadelphia: Elseiver, Churchill Livingstone, 2005:3347–3362. - Tompkins DC, Blackwell LJ, Hatcher VB, et al. Staphylococcus aureus proteins that bind to human
endothelial cells. Infect Immun 1992; 60:9 65–969. - Sheagren J. Staphylococcus aureus, the persistent pathogen. N Engl J Med 1984; 310:1368–1374.
- Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26:1179–1181.
- Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520–532.
- Chang F-Y, MacDonald BB, Peacock JE, et al. A prospective multicenter study of Staphylococcus
aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of
methicillin resistance. Medicine 2003; 82:322–332. - Gotz F, Peters G. Colonization of medical devices by coagulase negative staphylococci. In:
Waldvogel FA, Bisno Al, eds. Infections Associated with Indwelling Medical Devices. Washington
D.C.: ASM press, 2000:55–88. - Chu VH, Woods CW, Miro JM, et al. Emergence of coagulase- negative staphylococci as a cause a
native valve endocarditis. Clin Infect Dis 2008; 46:232–242. - Vandenesch F, Etienne J, Reverdy ME, et al. Endocarditis due to Staphylococcus lugdunensis:
report of 11 cases and review. Clin Infect Dis 1993; 17:871–876. - Doring J, Maier M, Mueller E. Virulence factors of pseudomonas aeruginosa. Antimicrob
Chemother 1987; 39:136–148. - Young F. Human immunity and Pseudomonas aeruginosa: in vitro interaction of bacteria,
polymorphonuclear leukocytes and serum factors. J Infect Dis 1972; 26:257–263. - Snyder N, Atterbury CE, Correia JP, et al. Increased occurrence of cirrhosis and bacterial
endocarditis. Gastroenterol 1977; 33:1107–1112. - Levine DP. Infectious endocarditis and intravenous drug abusers. In: Levine DP, Sobel JD, eds.
Infections Intravenous Drug Abusers. New York: Oxford University press, 1991:251–285.
250 Brusch